Journal article
Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin
JA Meyer, W Subasinghe, AAF Sima, Z Keltner, GE Reid, D Daleke, DM Spence
Molecular Biosystems | Published : 2009
DOI: 10.1039/b908241g
Abstract
Insulin resistance can broadly be defined as the diminished ability of cells to respond to the action of insulin in transporting glucose from the bloodstream into cells and tissues. Here, we report that erythrocytes (ERYs) obtained from type 2 diabetic rats display an apparent resistance to Zn 2+-activated C-peptide. Thus, the aims of this study were to demonstrate that Zn2+-activated C-peptide exerts potentially beneficial effects on healthy ERYs and that these same effects on type 2 diabetic ERYs are enhanced in the presence of metformin. Incubation of ERYs (obtained from type 2 diabetic BBZDR/Wor-rats) with Zn2+-activated C-peptide followed by chemiluminescence measurements of ATP resulte..
View full abstractGrants
Awarded by National Institute of Diabetes and Digestive and Kidney Diseases
Funding Acknowledgements
Support from the National Institutes of Health (DK071888) and the Thomas Foundation is appreciated. The Spence group would also like to thank the research group of Dr Jetze Tepe at Michigan State University for helping with the ELISA measurements and use of equipment.